BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


InSecta and Moscamed announce strategic marketing partnership for Medfly SIT

Deal will allow InSecta to market SIT medfly in the Mediterranean and stimulate SIT control programs

March 30th 2006: InSecta Ltd and The Moscamed Commission announced today that they have entered into a strategic agreement for InSecta to market Moscamed’s sterile medflies around the Mediterranean. The agreement, which allows InSecta exclusive rights in the region, is expected to stimulate the market for Sterile Insect Technique (SIT) control programs for Medfly.

Andrew Gardiner, Managing Director of InSecta said, “We are very pleased to be working with Moscamed, who are unquestionably the world’s leading producer of sterile flies. This deal not only allows InSecta to supply our customers with Moscamed’s flies, but also gives us access to their technical skills in implementing and supporting control programs. Over the last few years we have developed a network of contacts around the Mediterranean and recently have seen an increasing number of areas looking to start using SIT. We believe that our partnership with Moscamed will enable us to capitalise on the current opportunities and to drive the expansion of this ecological approach to insect pest control in the region.”

Gordon Tween, Program Director, Moscamed, said, “We believe that the Mediterranean market represents a valuable opportunity for Moscamed. Our partnership with InSecta gives us a chance to work with the leading commercial company in SIT and will help us to maximise sales of our insects in the Mediterranean.”

About InSecta. InSecta is a UK-based company with offices and operations in London, Spain and Slovakia. InSecta is focused on the commercial development of Medfly SIT around the Mediterranean.

About Moscamed. The Moscamed Commission is an international commission funded by the governments of Guatemala and the United States of America. It was established for the purpose of controlling and eradicating Mediterranean Fruit Fly in Central America. The capacity of Moscamed’s production facility in El Pino, Guatemala is currently more than 4 billion sterile flies every week.

About Medfly. The Mediterranean Fruit Fly (ceratitis capitata) is a major pest of citrus and other crops throughout the world. It is a highly invasive pest that can cause total loss of fruit production.

About SIT. The Sterile Insect Technique is based on the production and release of large numbers of sterile male insects that mate with the wild females, resulting in offspring which fail to develop. This causes the insect pest population to crash. SIT has been successfully used for control and eradication of Medfly and other insect pests in the USA, Canada, Japan, Australia, South Africa, Mexico & Chile. It has proved to be economical, environmentally sound and sustainable over huge areas. By providing a cost-effective alternative to chemicals it brings major economic, environmental and food-safety benefits to producers and consumers throughout the world.

For more information contact Andy Gardiner at InSecta on +44 20 7717 1566 or andy@insecta.co.uk
InSecta Ltd
90 London Road
London
SE1 6LN
UK

Moscamed
16th Street 3-38
Zona 10
Guatemala City
01010
Guatemala

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.